Brief: Biostage Q1 loss per share $0.18
12/05/2016 12:30
May 12 (Reuters) - Biostage Inc BSTG.O :
* Bioengineered organ implant developer Biostage reports q1
2016 results and hosts research update call today at 9:00 am et
* Q1 loss per share $0.18
Source text for Eikon: urn:newsml:reuters.com:*:nPn7FPKy5a
Further company coverage: BSTG.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer